Cholangiocarcinomas arising in cirrhosis and combined hepatocellular- cholangiocellular carcinomas share apomucin profiles

American Journal of Clinical Pathology

Volumn 109, Issue 3, 1998, Pages 302-308

  Sasaki, Motoko ^a   Nakanuma, Yasuni ^a   Ho, Samuel B ^b   Kim, Young S ^c  

^a KANAZAWA UNIVERSITY   (Japan)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Apomucin; Cholangiocarcinoma; Cirrhosis; Immunohistochemis try; MUC3; MUC5AC; MUC6; MUC7

Indexed keywords

MUCIN;

ARTICLE; BILE DUCT CARCINOMA; CANCER RISK; HISTOGENESIS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CIRRHOSIS; PRIORITY JOURNAL;

EID: 0031886072     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcp/109.3.302     Document Type: Article

References (41)

1. Nakanuma Y, Terada T, Tanaka Y, et al. Are hepatolithiasis and cholangiocarcinoma aetiologically related? a morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchow Arch A. 1985;406:45-58.
2. Nakanuma Y, Sasaki M, Terada T, et al. Intrahepatic peribiliary glands of humans, II: pathological spectrum. J Gastroenterol Hepatol. 1994;9:80-86.
3. Wee A, Ludwig J, Coffey RJ, et al. Hepatobiliary carcinoma associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hum Pathol. 1985;16:719-726.
4. Belamaric J. Intrahepatic bile duct carcinoma and C sinensis infection in Hong Kong. Cancer. 1973;31:468-473.
5. Honda N, Cobb C, Lechago J. Bile duct carcinoma associated with multiple von Meyenburg complexes in the liver. Hum Pathol. 1986;17:1287-1290.
6. Rubel LR, Usn CMC, Ishak KG. Thorotrast-associated cholangiocarcinoma: an epidemiologic and clinicopathologic study. Cancer. 1982;50:1408-1415.
7. Terada T, Kida T, Nakanuma Y, et al. Intrahepatic cholangiocarcinomas associated with nonbiliary cirrhosis. J Clin Gastroenterol. 1994;18:335-342.
8. Tomimatsu M, Ishiguro N, Taniai M, et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocellular carcinoma) in Japan. Cancer. 1993;72:683-688.
9. Ferlan-Marolt V, Markovic S. Clinicopathologic manifestation of primary liver carcinoma (PLC) in liver cirrhosis. Cancer Detect Prev. 1986;9:459-493.
10. Nakashima T, Okuda K, Kojiro M, et al. Pathology of hepatocellular carcinoma in Japan: 232 consecutive cases autopsied in ten years. Cancer. 1983,51:863-877.
11. Allen RA, Lisa JR. Combined liver cell and bile duct carcinoma. Am J Pathol 1949;25:647-655.
12. Goodman ZD, Ishak KG, Langloss JM, et al. Combined hepatocellular-cholangiocarcinoma: a histologic and immunohistochemical study. Cancer. 1985;55:124-135.
13. Neutra MR, Foretner JF. Gastrointestinal mucus: synthesis, secretion, and function. In: Johnson LR, ed. Physiology of the Gastrointestinal Tract. New York, NY: Raven Press; 1987:975-1009.
14. Gendler SJ, Lancaster CA, Taylor-Papadimitriou J, et al. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem. 1990;265:15286-15293.
15. Gum JR, Byrd JC, Hicks JW, et al. Molecular cloning of human intestinal mucin cDNAs. J Biol Chem. 1989;264:6480-6487.
16. Gum JR, Hicks JW, Swallow DM, et al. Molecular cloning of cDNAs derived from a novel human intestinal mucin gene. Biochem Biophys Res Comm. 1990;171:407-115.
17. Porchet N, Cong NV, Dufosse J, et al. Molecular cloning and chromosomal localization of a novel human tracheobronchial mucin cDNA containing tandemly repeated sequences of 48 base pairs. Biochem Biophys Res Comm. 1991;175:414-422.
18. Duffose J, Porchet N, Audie JP, et al. Degenerate 87 basepair tandem repeats create hydrophilic/hydrophobic alternating domains in human mucin peptides mapped to 11p15. Biochem J. 1993;293:329-337.
19. Toribara NW, Roberton AM, Ho SB, et al. Human gastric mucin: identification of a unique species by expression cloning. J Biol Chem. 1993;268:5879-5885.
20. Bobek LA, Tsai H, Biesbrock AR, et al. Molecular cloning, sequence, and specificity of expression of the gene encoding the low molecular weight human salivary mucin (MUC7). J Biol Chem. 1993;268:20563-20569.
21. Ho SB, Niehans GA, Lyftogt C, et al. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 1993;53:641-651.
22. Kim YS, Gum JR. Diversity of mucin genes, structure, function, and expression. Gastroenterology. 1995;109:999-1013.
23. Sasaki M, Nakanuma Y. Expression of mucin core protein of mammary type in primary liver cancer. Hepatology. 1994;20:1192-1197.
24. Sasaki M, Nakanuma Y, Kim YS. Characterization of apomucin expression in intrahepatic cholangiocarcinoma and their precursor lesions: an immunohistochemical study. Hepatology. 1996;24:1074-1078.
25. Okuda K, Kubo Y, Okazaki N, et al. Clinical aspects of intrahepatic cholangiocarcinoma including hilar carcinoma. Cancer. 1977;39:232-246.
26. Ho SB, Roberton AM, Shekels LL, et al. Expression cloning of gastric mucin complementary DNA and localization of mucin gene expression. Gastroenterology. 1995;109:735-747.
27. Hsu SM, Raine L. Fanger H. Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled (PAP) procedures. J Histochem Cytochem. 1981;29:577-580.
28. Torii T, Takahashi A, Dohi K. Statistics for Medicine and Biology [in Japanese]. Tokyo, Japan: Tokyo University Press; 1973:2-137.
29. Sasaki M, Nakanuma Y, Terada T, et al. Biliary epithelial expression of MUC1, MUC2, MUC3 and MUC5/6 apomucinsin during intrahepatic bile ducts development and maturation: an immunohistochemical study. Am J Pathol. 1995;147:574-579.
30. Sasaki M, Nakanuma Y, Kim YS. Expression of apomucins the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology. In press.
31. Balague C, Audie JP, Porchet N, et al. In situ hybridization shows distinct patterns of mucin gene expression in normal, benign, and malignant pancreas tissues. Gastroenterology. 1995;109:953-964.
32. Maeda T, Adachi E, Kajiyama K, et al. Combined hepatocellular and cholangiocarcinoma: proposed criteria according to clinicopathological features. Hum Pathol. 1995;26:956-964.
33. Thorgeirsson SS. Hepatic stem cells in liver regeneration. FASEBJ. 1996;10:1249-1256.
34. Golding M, Sarraf C, Lalani E, et al. Reactive biliary epithelium: the product of a pluripotential stem cell compartment? Hum Pathol. 1996;27:872-884.
35. Sell S, Pierce GB. Maturation arrest of stem cell differentiation is a common pathway for the cellular origin of teratocarcinomas and epithelial cancers. Lab Invest. 1994;70:6-22.
36. Marceau N. Cell lineages and differentiation programs in epidermal, urothelial and hepatic tissues and their neoplasms. Lab Invest. 1990;63:4-20.
37. Sell S, Dunsford HA. Evidence for the stem cell origin of hepatocellular carcinoma and cholangiocellular carcinoma. Am J Pathol 1989;134:1347-1363.
38. Tsao MS, Grisham JW, Nelson KG, et al. Phenotypic and karyotypic changes induced in cultured rat hepatic epithelial cells that express the 'oval' cell phenotype by exposure to N-methyl-N′-nitro-N-nitrosoguaninidine. Am J Pathol. 1985;118:306-315.
39. Tsao MS, Grisham JW. Hepatocarcinomas, cholangiocarcinomas, and hepatoblastomas produced by chemically transformed cultured rat liver epithelial cells: a light- and electron-microscopic analysis. Am J Pathol. 1987;127:168-181.
40. Steinberg P, Steinbreches R, Radaeve S, et al. Oval cell lines OC/CDE 6 and OC/CDE 22 give rise to cholangio-cellular and undifferentiates carcinoma after transformation. Lab Invest. 1994;71:700-709.
41. Wu PC, Fang JWS, Lau VKT, et al. Classification of hepatocellular carcinoma according to hepatocellular and biliary differentiation markers. Am J Pathol. 1996;149:1167-1175.